Review

bamlanivimab (Eli Lilly)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Eli Lilly bamlanivimab
Bamlanivimab, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bamlanivimab/bamlanivimab/pmc12650576-271-17-23
Average 86 stars, based on 1 article reviews

bamlanivimab - by Bioz Stars, 2026-09

86/100 stars

Images

other:

Article Title: A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodies
Article Snippet: Bamlanivimab , Eli Lilly (USA) , Nov 2020 (FDA) , Alpha, Beta, Delta , Revoked Apr 2021 (Delta/Omicron).

Recombinant:

Article Title: Protein Engineering and Drug Discovery: Importance, Methodologies, Challenges, and Prospects
Article Snippet: .. Recombinant proteins have become energetic in the treatment of infectious diseases, particularly through mAb therapies, such as Bamlanivimab, a monoclonal antibody developed by Eli Lilly, which received Emergency Use Authorization (EUA) for the treatment of SARS-COV-2 [ ] ( ). ..

Binding Assay:

Article Title: High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping
Article Snippet: .. Using the MITOMI approach , we measured the binding affinities of two antibodies previously used as therapeutics, Bamlanivimab (Eli Lilly, LY-CoV555) and Imdevimab (Regeneron, REGN10987), due to their distinct neutralisation profiles against variants of concern, and a novel binder DBR3_03 , as it has computationally designed broad-spectrum efficacy ( ). ..